Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.

Lin YC, Huang GD, Hsieh CW, Wung BS.

Free Radic Biol Med. 2012 May 1;52(9):1844-53. doi: 10.1016/j.freeradbiomed.2012.02.028. Epub 2012 Mar 1.

PMID:
22387200
[PubMed - indexed for MEDLINE]
2.

The glutaredoxin/glutathione system modulates NF-kappaB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells.

Liao BC, Hsieh CW, Lin YC, Wung BS.

Toxicol Sci. 2010 Jul;116(1):151-63. doi: 10.1093/toxsci/kfq098. Epub 2010 Mar 29.

PMID:
20351055
[PubMed - indexed for MEDLINE]
Free Article
3.

Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.

Song NY, Kim DH, Kim EH, Na HK, Kim NJ, Suh YG, Surh YJ.

Chem Res Toxicol. 2011 Aug 15;24(8):1231-41. doi: 10.1021/tx200090n. Epub 2011 Jul 25.

PMID:
21728338
[PubMed - indexed for MEDLINE]
4.

The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.

Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.

Life Sci. 2009 Jul 3;85(1-2):46-53. doi: 10.1016/j.lfs.2009.04.010. Epub 2009 May 3.

PMID:
19409914
[PubMed - indexed for MEDLINE]
5.

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.

Cernuda-Morollón E, Pineda-Molina E, Cañada FJ, Pérez-Sala D.

J Biol Chem. 2001 Sep 21;276(38):35530-6. Epub 2001 Jul 20.

PMID:
11466314
[PubMed - indexed for MEDLINE]
Free Article
6.

15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.

Lee DR, Kwon CH, Park JY, Kim YK, Woo JS.

Toxicology. 2009 Apr 5;258(1):17-24. doi: 10.1016/j.tox.2009.01.001. Epub 2009 Jan 9.

PMID:
19167456
[PubMed - indexed for MEDLINE]
7.

15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.

Reyes-Martin P, Ramirez-Rubio S, Parra-Cid T, Bienes-Martínez R, Lucio-Cazana J.

Pharmacol Res. 2008 May;57(5):344-50. doi: 10.1016/j.phrs.2008.03.007. Epub 2008 Mar 26.

PMID:
18456507
[PubMed - indexed for MEDLINE]
8.

CO-releasing molecules and increased heme oxygenase-1 induce protein S-glutathionylation to modulate NF-κB activity in endothelial cells.

Yeh PY, Li CY, Hsieh CW, Yang YC, Yang PM, Wung BS.

Free Radic Biol Med. 2014 May;70:1-13. doi: 10.1016/j.freeradbiomed.2014.01.042. Epub 2014 Feb 7.

PMID:
24512908
[PubMed - in process]
9.

15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes.

Lee E, Yin Z, Sidoryk-Węgrzynowicz M, Jiang H, Aschner M.

Free Radic Biol Med. 2012 Mar 15;52(6):1067-74. doi: 10.1016/j.freeradbiomed.2011.12.016. Epub 2011 Dec 29.

PMID:
22245093
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK.

Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4844-9.

PMID:
10781090
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.

Kang DS, Kwon CH, Park JY, Kim JH, Woo JS, Jung JS, Kim YK.

Toxicol Appl Pharmacol. 2006 Nov 1;216(3):426-35. Epub 2006 Jun 27.

PMID:
16890972
[PubMed - indexed for MEDLINE]
13.

15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.

Song NY, Kim DH, Kim EH, Na HK, Surh YJ.

Ann N Y Acad Sci. 2009 Aug;1171:210-6. doi: 10.1111/j.1749-6632.2009.04914.x.

PMID:
19723058
[PubMed - indexed for MEDLINE]
14.

15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.

Boyault S, Bianchi A, Moulin D, Morin S, Francois M, Netter P, Terlain B, Bordji K.

FEBS Lett. 2004 Aug 13;572(1-3):33-40.

PMID:
15304320
[PubMed - indexed for MEDLINE]
Free Article
15.

15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.

Okano H, Shiraki K, Inoue H, Yamanaka Y, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Yamamoto N, Sugimoto K, Murata K, Nakano T.

Lab Invest. 2003 Oct;83(10):1529-39.

PMID:
14563954
[PubMed - indexed for MEDLINE]
17.

15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53.

Ho TC, Chen SL, Yang YC, Chen CY, Feng FP, Hsieh JW, Cheng HC, Tsao YP.

J Biol Chem. 2008 Oct 31;283(44):30273-88. doi: 10.1074/jbc.M804196200. Epub 2008 Aug 21.

PMID:
18718914
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Dual mechanisms of NF-kappaB inhibition in carnosol-treated endothelial cells.

Lian KC, Chuang JJ, Hsieh CW, Wung BS, Huang GD, Jian TY, Sun YW.

Toxicol Appl Pharmacol. 2010 May 15;245(1):21-35. doi: 10.1016/j.taap.2010.01.003. Epub 2010 Jan 29.

PMID:
20116392
[PubMed - indexed for MEDLINE]
19.

15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.

Piva R, Gianferretti P, Ciucci A, Taulli R, Belardo G, Santoro MG.

Blood. 2005 Feb 15;105(4):1750-8. Epub 2004 Oct 21.

PMID:
15498850
[PubMed - indexed for MEDLINE]
Free Article
20.

Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.

Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T.

Clin Cancer Res. 2010 Apr 15;16(8):2320-32. doi: 10.1158/1078-0432.CCR-09-2301. Epub 2010 Apr 6.

PMID:
20371690
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk